Laurus Labs Ltd

According to media reports, the pharmaceutical company's export revenue declined 47% to about $36 million in February, reflecting a significant slowdown in overseas sales. Laurus Labs is a research-driven pharmaceutical and biotechnology company. It holds a leadership position in developing and manufacturing select Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDF) across anti-retroviral, oncology, cardiovascular, and gastro therapeutics. On a consolidated basis, Laurus Labs net profit rose 172.65% to Rs 251.66 crore while net sales rose 25.67% to Rs 1778.29 crore in Q3 December 2025 over Q3 December 2024. Powered by Capital Market - Live

Laurus Labs Ltd gained for a third straight session today. The stock is quoting at Rs 1027.95, up 1.44% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.04% on the day, quoting at 25713.95. The Sensex is at 83408.99, down 0.05%. Laurus Labs Ltd has slipped around 3.27% in last one month. Meanwhile, Nifty Pharma index of which Laurus Labs Ltd is a constituent, has slipped around 1.73% in last one month and is currently quoting at 22494.9, up 0.1% on the day. The volume in the stock stood at 7.19 lakh shares today, compared to the daily average of 21.68 lakh shares in last one month. The benchmark February futures contract for the stock is quoting at Rs 1030.5, up 1.47% on the day. Laurus Labs Ltd is up 88.01% in last one year as compared to a 12.13% spurt in NIFTY and a 8.16% spurt in the Nifty Pharma index.The PE of the stock is 68.35 based on TTM earnings ending December 25.Powered by Capital Market - Live

Laurus Labs Ltd is down for a fifth straight session today. The stock is quoting at Rs 944.45, down 2.13% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.8% on the day, quoting at 25118.1. The Sensex is at 81829.23, down 0.54%.Laurus Labs Ltd has lost around 14.65% in last one month.Meanwhile, Nifty Pharma index of which Laurus Labs Ltd is a constituent, has eased around 5.07% in last one month and is currently quoting at 21715.1, down 0.37% on the day. The volume in the stock stood at 11.2 lakh shares today, compared to the daily average of 23.57 lakh shares in last one month. The benchmark February futures contract for the stock is quoting at Rs 948.75, down 2.06% on the day. Laurus Labs Ltd jumped 61.07% in last one year as compared to a 7.52% rally in NIFTY and a 1.28% spurt in the Nifty Pharma index.The PE of the stock is 65.08 based on TTM earnings ending December 25.Powered by Capital Market - Live

Net profit of Laurus Labs rose 172.65% to Rs 251.66 crore in the quarter ended December 2025 as against Rs 92.30 crore during the previous quarter ended December 2024. Sales rose 25.67% to Rs 1778.29 crore in the quarter ended December 2025 as against Rs 1415.05 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales1778.291415.05 26 OPM %27.0020.15 - PBDT447.18236.77 89 PBT326.56130.68 150 NP251.6692.30 173 Powered by Capital Market - Live

Laurus Labs will hold a meeting of the Board of Directors of the Company on 23 January 2026.Powered by Capital Market - Live

Laurus Labs Ltd is up for a fifth straight session today. The stock is quoting at Rs 1069.2, up 0.47% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.01% on the day, quoting at 26175.65. The Sensex is at 85535.57, down 0.04%. Laurus Labs Ltd has gained around 9.15% in last one month. Meanwhile, Nifty Pharma index of which Laurus Labs Ltd is a constituent, has gained around 1.82% in last one month and is currently quoting at 22927.9, down 0.11% on the day. The volume in the stock stood at 6.85 lakh shares today, compared to the daily average of 14.78 lakh shares in last one month. The benchmark December futures contract for the stock is quoting at Rs 1071.9, up 0.58% on the day. Laurus Labs Ltd is up 88.52% in last one year as compared to a 10.32% jump in NIFTY and a 1.52% jump in the Nifty Pharma index.The PE of the stock is 84.06 based on TTM earnings ending September 25.Powered by Capital Market - Live

Laurus Labs Ltd gained for a third straight session today. The stock is quoting at Rs 1033.9, up 1.81% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.53% on the day, quoting at 25951.35. The Sensex is at 84911.21, up 0.51%. Laurus Labs Ltd has risen around 4.74% in last one month. Meanwhile, Nifty Pharma index of which Laurus Labs Ltd is a constituent, has risen around 0.3% in last one month and is currently quoting at 22557.6, up 0.27% on the day. The volume in the stock stood at 19.64 lakh shares today, compared to the daily average of 14.12 lakh shares in last one month. The benchmark December futures contract for the stock is quoting at Rs 1035.7, up 1.65% on the day. Laurus Labs Ltd is up 84.89% in last one year as compared to a 10.02% spurt in NIFTY and a 0.52% spurt in the Nifty Pharma index.The PE of the stock is 80.25 based on TTM earnings ending September 25.Powered by Capital Market - Live

Laurus Labs has allotted 31,683 equity shares under ESOP on 02 December 2025. The total paid up capital of the Company after the above allotment stands at Rs.1,07,97,13,164/-.Powered by Capital Market - Live

Laurus Labs Ltd is up for a third straight session in a row. The stock is quoting at Rs 1029.75, up 2.65% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.03% on the day, quoting at 26207.8. The Sensex is at 85741.54, up 0.02%. Laurus Labs Ltd has added around 7.08% in last one month. Meanwhile, Nifty Pharma index of which Laurus Labs Ltd is a constituent, has added around 2.21% in last one month and is currently quoting at 22863, up 0.28% on the day. The volume in the stock stood at 15.83 lakh shares today, compared to the daily average of 17.42 lakh shares in last one month. The benchmark December futures contract for the stock is quoting at Rs 1034.6, up 2.29% on the day. Laurus Labs Ltd is up 81.57% in last one year as compared to a 8.61% gain in NIFTY and a 3.08% gain in the Nifty Pharma index.The PE of the stock is 79.4 based on TTM earnings ending September 25.Powered by Capital Market - Live

Net profit of Laurus Labs rose 882.71% to Rs 194.97 crore in the quarter ended September 2025 as against Rs 19.84 crore during the previous quarter ended September 2024. Sales rose 35.12% to Rs 1653.47 crore in the quarter ended September 2025 as against Rs 1223.70 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales1653.471223.70 35 OPM %24.3914.57 - PBDT390.22130.32 199 PBT269.7322.81 1083 NP194.9719.84 883 Powered by Capital Market - Live